Merck & Co Inc
NYSE: MRK
$96.40
-$1.96 (-2.0%)
Real Time Data Delayed 15 Min.
MRK Articles
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the remainder of October.
Published:
Last Updated:
These five well-known stocks may be laggards but they look like they have solid upside potential, and all can help add alpha to portfolios.
Published:
Last Updated:
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Nike's risky new ad campaign featuring NFL player Colin Kaepernick has paid off in higher sales and increased attention from analysts who have raised ratings and price targets and said lots of nice...
Published:
Last Updated:
Apple, IBM, Merck, and Travelers buoyed the Dow index on Thursday.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Apple held on to its position as the best performing Dow stock for the year to date last week. Next Wednesday the company will introduce new iPhones and other products to the Apple faithful.
Published:
Last Updated:
Boeing, Visa, Merck, and Verizon posted large enough gains to keep the Dow in the green Thursday.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple the position as the best performing Dow stock of 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Published:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.
Published:
Last Updated: